KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) EBT Margin: 2009-2014

Historic EBT Margin for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -372.40%.

  • Biocryst Pharmaceuticals' EBT Margin rose 26584.00% to -129.87% in Q3 2015 from the same period last year, while for Sep 2015 it was -93.64%, marking a year-over-year increase of 12956.00%. This contributed to the annual value of -372.40% for FY2014, which is 16813.00% down from last year.
  • Biocryst Pharmaceuticals' EBT Margin amounted to -372.40% in FY2014, which was down 82.31% from -204.27% recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' EBT Margin registered a high of -54.27% during FY2010, and its lowest value of -372.40% during FY2014.
  • In the last 3 years, Biocryst Pharmaceuticals' EBT Margin had a median value of -204.27% in 2013 and averaged -240.82%.
  • Its EBT Margin has fluctuated over the past 5 years, first crashed by 21,528bps in 2011, then soared by 12,376bps in 2012.
  • Biocryst Pharmaceuticals' EBT Margin (Yearly) stood at -54.27% in 2010, then plummeted by 21,528bps to -269.55% in 2011, then skyrocketed by 12,376bps to -145.79% in 2012, then tumbled by 5,848bps to -204.27% in 2013, then slumped by 16,813bps to -372.40% in 2014.